Javascript must be enabled to continue!
Mood instability, depression, and anxiety in pregnancy and adverse neonatal outcomes
View through CrossRef
Abstract
Background
Antenatal women experience an increased level of mood and anxiety symptoms, which have negative effects on mothers’ mental and physical health as well as the health of their newborns. The relation of maternal depression and anxiety in pregnancy with neonate outcomes is well-studied with inconsistent findings. However, the association between antenatal mood instability (MI) and neonatal outcomes has not been investigated even though antenatal women experience an elevated level of MI. We sought to address this gap and to contribute to the literature about pregnancy neonate outcomes by examining the relationship among antenatal MI, depression, and anxiety and neonatal outcomes.
Methods
A prospective cohort of women (n = 555) participated in this study at early pregnancy (T1, 17.4 ± 4.9 weeks) and late pregnancy (T2, 30.6 ± 2.7 weeks). The Edinburgh Postnatal Depression Scale (EPDS) was used to assess antenatal depressive symptoms, anxiety was measured by the EPDS anxiety subscale, and mood instability was measured by a visual analogue scale with five questions. These mood states together with stress, social support, as well as lifestyle were also examined in relation to neonatal outcomes using chi-square tests and logistic regression models.
Results
Mood instability, depression, and anxiety were unrelated to adverse neonatal outcomes. Only primiparous status was associated with small for gestational age after Bonferroni correction.
Conclusions
We report no associations between antenatal mood symptoms including MI, depression, and anxiety and neonatal outcomes. More studies are required to further explore the relationship between antenatal mood instability, depression, and anxiety and neonatal outcomes.
Springer Science and Business Media LLC
Title: Mood instability, depression, and anxiety in pregnancy and adverse neonatal outcomes
Description:
Abstract
Background
Antenatal women experience an increased level of mood and anxiety symptoms, which have negative effects on mothers’ mental and physical health as well as the health of their newborns.
The relation of maternal depression and anxiety in pregnancy with neonate outcomes is well-studied with inconsistent findings.
However, the association between antenatal mood instability (MI) and neonatal outcomes has not been investigated even though antenatal women experience an elevated level of MI.
We sought to address this gap and to contribute to the literature about pregnancy neonate outcomes by examining the relationship among antenatal MI, depression, and anxiety and neonatal outcomes.
Methods
A prospective cohort of women (n = 555) participated in this study at early pregnancy (T1, 17.
4 ± 4.
9 weeks) and late pregnancy (T2, 30.
6 ± 2.
7 weeks).
The Edinburgh Postnatal Depression Scale (EPDS) was used to assess antenatal depressive symptoms, anxiety was measured by the EPDS anxiety subscale, and mood instability was measured by a visual analogue scale with five questions.
These mood states together with stress, social support, as well as lifestyle were also examined in relation to neonatal outcomes using chi-square tests and logistic regression models.
Results
Mood instability, depression, and anxiety were unrelated to adverse neonatal outcomes.
Only primiparous status was associated with small for gestational age after Bonferroni correction.
Conclusions
We report no associations between antenatal mood symptoms including MI, depression, and anxiety and neonatal outcomes.
More studies are required to further explore the relationship between antenatal mood instability, depression, and anxiety and neonatal outcomes.
Related Results
Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
IntroductionLike other forms of embodiment, pregnancy has increasingly become subject to representation and interpretation via digital technologies. Pregnancy and the unborn entity...
Mood Symptoms and Other Maternal Factors in Pregnancy and Adverse Neonate Outcomes
Mood Symptoms and Other Maternal Factors in Pregnancy and Adverse Neonate Outcomes
Abstract
Background Antenatal women experience a higher level of mood symptoms, which have negative effects on mothers’ mental and physical health and their newborns. The r...
Nutrition in pregnancy
Nutrition in pregnancy
SUMMARY
INTRODUCTION
PHYSIOLOGICAL CHANGES DURING PREGNANCY
Changes in body composition and weight gain
Changes in blood composition
Metabolic changes and adaptive responses
K...
Stress-related mental disorders : an exploration astrocytic biomarkers, comorbidities, and cognition
Stress-related mental disorders : an exploration astrocytic biomarkers, comorbidities, and cognition
<p dir="ltr">Background</p><p dir="ltr">Prolonged exposure to stressors without sufficient recovery can lead to physical and mental symptoms. In Sweden, individua...
Stress-related mental disorders : an exploration astrocytic biomarkers, comorbidities, and cognition
Stress-related mental disorders : an exploration astrocytic biomarkers, comorbidities, and cognition
<p dir="ltr">Background</p><p dir="ltr">Prolonged exposure to stressors without sufficient recovery can lead to physical and mental symptoms. In Sweden, individua...
The Effects of Induced Mood on Curiosity in College Students
The Effects of Induced Mood on Curiosity in College Students
The investigation discussed herein sought to (a) examine the relationship between curiosity and depression, (b) investigate the effects of induced mood on factors of surprise, perc...
Heritability and polygenic load for combined anxiety and depression
Heritability and polygenic load for combined anxiety and depression
Abstract
Anxiety and depression commonly occur together resulting in worse health outcomes than when they occur in isolation. We aimed to determi...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

